Range Low Price High Price Comment
30 days $0.535 $0.97 Thursday, 28th Mar 2024 ADXS stock ended at $0.640. This is 8.57% less than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 12.50% from a day low at $0.640 to a day high of $0.720.
90 days $0.511 $1.49
52 weeks $0.511 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
2023-08-23 $1.00 $1.10 $1.00 $1.02 4 731
2023-08-22 $1.05 $1.05 $1.00 $1.02 1 142
2023-08-21 $1.03 $1.10 $1.00 $1.00 9 900
2023-08-18 $1.02 $1.05 $1.01 $1.04 4 105
2023-08-17 $1.05 $1.06 $1.01 $1.01 1 306
2023-08-16 $1.07 $1.07 $1.05 $1.05 860
2023-08-15 $1.05 $1.17 $1.05 $1.06 4 465
2023-08-14 $1.15 $1.15 $0.88 $1.10 6 907
2023-08-11 $1.23 $1.23 $1.10 $1.14 3 810
2023-08-10 $1.23 $1.23 $1.23 $1.23 2 054
2023-08-09 $1.23 $1.23 $1.23 $1.23 1 091
2023-08-08 $1.15 $1.19 $1.15 $1.19 1 554
2023-08-07 $1.10 $1.25 $1.10 $1.15 1 813
2023-08-04 $1.11 $1.18 $1.10 $1.10 5 599
2023-08-03 $1.22 $1.22 $1.11 $1.11 438
2023-08-02 $1.15 $1.31 $1.15 $1.17 5 706
2023-08-01 $1.07 $1.17 $1.07 $1.17 3 923
2023-07-31 $1.15 $1.19 $1.06 $1.09 3 577
2023-07-28 $1.11 $1.19 $1.10 $1.17 4 243
2023-07-27 $1.08 $1.12 $1.08 $1.10 8 693
2023-07-26 $1.06 $1.06 $0.96 $1.01 19 155
2023-07-25 $1.27 $1.30 $1.03 $1.08 32 407
2023-07-24 $1.48 $1.95 $1.33 $1.35 31 933
2023-07-21 $1.04 $1.72 $1.04 $1.38 63 319
2023-07-20 $1.02 $1.02 $0.85 $0.90 1 385
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT